# Omega-3 fatty acid drugs

Drug · id `cardio:omega-3-fatty-acid-drugs` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Omega-3 fatty acids; Fatty Acids, Omega-3

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

Omega-3 fatty acid drugs are medicines made from omega-3 fatty acids. MeSH describes omega-3 fatty acids as unsaturated fatty acids found mainly in fish oils. The US label for icosapent ethyl (Vascepa) says it is an ethyl ester of the omega-3 fatty acid EPA, and its page is filed under this class. This is the class page.

## Technical summary

Class page. MeSH descriptor D015525 (Fatty Acids, Omega-3) is a broad match: it names a group of fatty acids found mainly in fish oils, not a group of medicines. The Vascepa label read (NDA202057, effective 2026-03-23 in openFDA; the source record already in the atlas) says icosapent ethyl is an ethyl ester of the omega-3 fatty acid eicosapentaenoic acid (EPA), that the product contains ethyl esters of that acid obtained from fish oil, and that it is indicated as an adjunct to diet for severe hypertriglyceridemia. Icosapent ethyl is filed under this page on that evidence. RxClass returned no class for icosapent ethyl (read 2026-11-18, hash only). Only the Vascepa label was read, so one label stands for the class. No trial result and no dose is recorded.

## Connected pages

- Files under this front: Medicines (`cardio:front-medicines`)
- A US label for an omega-3 ester lists severe hypertriglyceridemia among its uses: High triglycerides (`cardio:hypertriglyceridemia`)
- Has subtype: Icosapent ethyl (`cardio:icosapent-ethyl`)

## Provenance

Content hash: 0f6393ac0145f00b4e8597494721c41bb733cc1fff6ec18eea10234b58c17ee7
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
